Dividend income is often overlooked amid gyrations in the stock market. But dividends are an important element of return. Dividend income accounted for 42% of the total return of the S&P 500 between 1930 and 2012, according to Hartford Funds. And that's just the average. In some of those decades, dividends accounted for more than 50% of total returns and even 100% of returns. More recently, dividends have accounted for a smaller portion of returns, at around 15%-20%. Not for nothing, in 2022, dividend payments softened the blow when most market indices turned bearish as the Federal Reserve hiked interest rates. Not all dividends are created equal, though, and it is important to understand the difference between the two main categories: high-yield stocks and dividend-growth stocks. High-yield stocks typically have dividends that pay out in the 5%-8% range. Though the income appears attractive, the share prices of high-yield stocks could signal some risks. Dividend-growth stocks typically have lower yields, often in the 1.0%-2.5% range. But the lower-yielding dividends are not likely to be a huge component of cash flow, leaving management teams with other value-additive options for deploying cash -- such as share buybacks, M&A, the repayment of debt, or reinvestment in the core business. Below is a partial list of Argus BUY-rated stocks that are included in our June Dividend Growth Theme Model Portfolio.

The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

By revenue, UnitedHealth Group is the nation's largest publicly traded managed care company. It operates through two business segments, UnitedHealthcare and Optum. UnitedHealthcare provides healthcare benefits through four membership groups: Employers & Individual, Medicare & Retirement, Community & State, and International. Optum is a health services business that serves payers, care providers, employers, governments, life science companies, and consumers. OptumInsight uses advanced data analytics and technology to help optimize the performance of clients. Optum includes OptumRx, which operates a pharmacy benefit management service (PBM).

The overall stock market had another very good day on July 16 -- but, once again, it was because of the now-loved (at least for now) little guys. To put this into perspective, the total market cap of the Russell 2000 (IWM) is said to be only as large as one of the multiple $3 trillion market-cap stocks in the 'Magnificent 7.' But let's not spoil the party as stocks are posting some historical returns on massive trading volume. Over the past five days, IWM has soared 11.5%. Excluding the comeback from the pandemic, the index has logged the greatest five-day period since October 2011. Before that, you have to go back to the initial rally after the March 2009 bear-market low to find such a move. The IWM is now only nine points (or about 4%) from its November 8, 2021, all-time high. It has completed a massive 31-month consolidation and, as they say, the larger the base, the higher in space. Over the past four days, IWM volume has exploded as investors have piled into the small-cap trade. The four-day volume totaled 227.4 million shares or 56.9 mln./day. The 50-day average for volume is 26.5 mln. shares and the 200-day average is 36 mln. shares. This is the largest cluster of volume during an IWM rally since December. Almost always, large clusters of huge volume happen during corrections and bear markets and many times represent downside capitulation. Market breadth has obviously been strong, with the four-day NYSE advances-declines hitting +1,004. This is a short-term breadth thrust and is usually associated with the beginning of an advance.